Skip to main content
    E

    enGene Therapeutics Inc. (ENGN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.89
    -0.52 (-21.58%)

    Market Cap: $161.51M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    enGene Therapeutics Inc. (ENGN) Earnings: Report Dates and Results

    Updated Sep 8, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    enGene Therapeutics (ENGN) is expected to report earnings on Dec 22, 2026. In the quarter ended Jul 31, 2026, enGene Therapeutics reported EPS of $0.47, above the -$0.44 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    55%(6/11)
    Avg Surprise
    +12.95%
    Streak
    3 Q

    Upcoming Estimates

    Reports Dec 22, 2026 (est.)Period ending Oct 31, 2026
    EPS Consensus-$0.47
    Range-$0.54 - -$0.38
    11 analysts
    Revenue Consensus
    N/A
    RangeN/A
    10 analysts
    Reports Mar 8, 2027 (est.)Period ending Jan 31, 2027
    EPS Consensus-$0.38
    Range-$0.44 - -$0.30
    3 analysts
    EPS Revisions
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.31-22.8%
    60d ago-$0.34-10.8%
    30d ago-$0.34-10.8%
    7d ago-$0.34-10.8%
    Current-$0.38
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts

    Next Report

    ENGN has an expected report date of Dec 22, 2026.

    Earnings History

    Of the 11 quarters below that had an estimate, ENGN beat 6 and missed 5. The widest gap in the table came in the quarter ended Jul 31, 2026, when EPS landed 206.82% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Jul 31, 2026$0.47-$0.44-$0.51 - -$0.35+206.82%BeatN/A88 up, 0 downSep 8, 2026
    Apr 30, 2026-$0.43-$0.48-$0.51 - -$0.44+10.42%BeatN/A92 up, 1 downJun 15, 2026
    Jan 31, 2026-$0.44-$0.57-$0.65 - -$0.48+23.32%BeatN/A83 up, 2 downMar 9, 2026
    Oct 31, 2025-$0.73-$0.58-$0.63 - -$0.52-25.86%MissN/A80 up, 1 downDec 22, 2025
    Jul 31, 2025-$0.57-$0.51-$0.57 - -$0.43-11.76%MissN/A83 up, 3 downSep 10, 2025
    Apr 30, 2025-$0.51-$0.48-$0.60 - -$0.32-6.25%MissN/A90 up, 5 downJun 12, 2025
    Jan 31, 2025-$0.48-$0.37-$0.43 - -$0.31-29.73%MissN/A93 up, 0 downMar 10, 2025
    Oct 31, 2024-$0.34-$0.36-$0.45 - -$0.25+5.56%BeatN/A71 up, 0 downDec 19, 2024
    Jul 31, 2024-$0.32-$0.35-$0.52 - -$0.17+8.57%BeatN/A60 up, 0 downSep 10, 2024
    Apr 30, 2024-$0.38-$0.27-$0.35 - -$0.20-40.74%MissN/A50 up, 0 downJun 14, 2024
    Jan 31, 2024-$0.46-$0.47N/A+2.13%Beat-1250.0%N/AN/AMar 11, 2024
    Oct 31, 2023-$4.51N/AN/AN/AN/A-11609.9%N/AN/AJan 29, 2024
    Jul 31, 2023$0.00N/AN/AN/AN/AN/AN/AN/AJul 31, 2023
    Apr 30, 2023-$0.17N/AN/AN/AN/AN/AN/AN/AJun 30, 2023
    Jan 31, 2023$0.04N/AN/AN/AN/AN/AN/AN/AApr 30, 2023
    Oct 31, 2022$0.04N/AN/AN/AN/AN/AN/AN/ANov 10, 2022
    Jul 31, 2022-$0.02N/AN/AN/AN/AN/AN/AN/AAug 11, 2022
    Apr 30, 2022-$0.03N/AN/AN/AN/AN/AN/AN/AMay 13, 2022
    Jan 31, 2022-$0.01N/AN/AN/AN/AN/AN/AN/AApr 30, 2022
    Oct 31, 2021Not reportedN/AN/AN/ANot reportedN/AN/AN/ADec 30, 2021
    Last 20 quarters

    Annual EPS

    EPS for the fiscal year ended Oct 31, 2026 was -$0.40, after -$2.29 the year before. It was -$0.02 for the year ended Oct 31, 2022, the oldest of the 5 fiscal years below with reported EPS.

    Fiscal year endedEPSChange
    Oct 31, 2026-$0.40N/A
    Oct 31, 2025-$2.29N/A
    Oct 31, 2024-$1.50N/A
    Oct 31, 2023-$4.65N/A
    Oct 31, 2022-$0.02N/A
    Oct 31, 2021Not reportedN/A

    Frequently Asked Questions About ENGN

    When is enGene Therapeutics's next earnings date?

    enGene Therapeutics's next earnings report is expected for Dec 22, 2026.

    Did ENGN beat earnings estimates last quarter?

    Yes. enGene Therapeutics reported EPS of $0.47 for the quarter ended Jul 31, 2026, above the -$0.44 estimate, a 206.82% surprise.

    What EPS do analysts expect from ENGN next quarter?

    The consensus EPS estimate for enGene Therapeutics for the quarter ended Oct 31, 2026 is -$0.47 from 11 analysts, with estimates from -$0.54 to -$0.38.

    How often does ENGN beat earnings estimates?

    enGene Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +21.56%.